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With regard to anticoagulation
agents, we did not previously use
warfarin in any small patients because
of the complexity of warfarin control.
However, we have recently used war-
farin in patients with artificial valve re-
placement or suboptimal conditions
after the Fontan operation.
Regardless of the methods used for
evaluating Fontan candidates, we be-
lieve that themost important evaluation
parameters are pulmonary vascular re-
sistance, pulmonary artery pressure,
and atrial pressure or ventricular end-di-
astolic pressure in patients undergoing
the bidirectional Glenn procedure. We
showed the Nakata index as the refer-
ence morphologic index for the pulmo-
nary vascular tree to comparewith other
study groups, because the body size of
our patients was relatively small and
there were no alternative conventional
indicators of the pulmonary vascular
tree.
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CHALLENGES OF SMALL
CARDIAC UNITS
To the Editor:
We read with interest the recent
articles by Shahian and Normand1 and
Carey and colleagues2 and would like
to shed some light on the current prac-
tice of small cardiac units in the Middle
East and third world countries. Numer-
ous cardiac care units are located in sev-
eral hospitals throughout a single city,
and approximately 100 open surgeries
are performed each year in these units.
Many hospital administrations are rac-
ing and competing with each other to
provide this delicate and highly sophis-
ticated service without detailed under-
standing of the magnitude and finicial
commitment. It has to be emphesized
that cardiac surgery, although highly
needed and vital, is a complex, compre-
hensive and multidisciplinary subspe-
ciality. Vast financial resources are
needed to provide the nursing and med-
ical staff, and cardiology and cardiac
surgery equipment. Unfortunately,
there is no administrative collaboration
or even communication to obtain at
least a satisfactory output. These small
units share similar features and face
the same difficulties and obstacles, in-
cluding unsteady patient volume and
flow, and a series of average cases fol-
lowed by difficult high-risk cases. The
overall setup is substandard and aimed
for business, profit, and fame based
on the attraction of more patients cus-
tomers called to other subspecialties.
Emergency catheter laboratory compli-
cations add to the problems and in-
crease the surgical risk. Limited
intensive care beds, limited nurse/staff
coverage, and cardiac anesthesia short-
ages exist because these units are run
with limited resources and 1 or 2 anes-
thetists working 1 or 2 days per week
and involved with general surgery the
rest of the week.
Each cardiac case requires an exten-
sive arrangement of blood and blood
products, intensive care unit beds and
anesthesia during the day of surgery,
and night coverage at least for the first
night. The cardiac surgeon bears most
of the responsibility. Each morbidity
or mortality dramatically worsens the
results. The overall system arrange-
ment is suboptimal, with marginal
benefit and substantial cost.
Administrators and health providers
have to be aware of such problems.
Cardiac surgery cannot attain the
expected productivity unless the nec-
essary professionals and adequate re-
sources are provided. Full coverage,
24 hours per day, 7 days per week, of
diagnostic services, elective and emer-
gency operations, post operative fol-
lowup and rehabilitation, are crucial
for success of these programs.
Khaled E. Al-Ebrahim, MbbCh,
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Dr Al-Ebrahim’s Letter to the Edi-
tor reinforces an important concept
from our article. The fact that some
lower-volume cardiac surgery pro-
grams have achieved excellent results
should not be viewed as a general en-
dorsement for developing more such
programs. The justification for any
new cardiac surgery program must
be critically evaluated, including the
adequacy of resources and referral
base.
Ideally, such new programs are
developed to serve populations who
have no other local or regional access
to cardiac surgery. To be successful,
smaller cardiac surgery programs
must be provided with the substantial
hospital resources necessary to care
for these complex patients. They
should also be encouraged to use the
strategies mentioned in our commen-
tary to help compensate for their
smaller volumes.008
Letters to the EditorThe scenario described by Dr
Al-Ebrahim is quite different and cer-
tainly undesirable—the regional pro-
liferation of small cardiac surgery
programs without adequate justifica-
tion, planning, resources, or infrastruc-
ture. Whatever the initial motivation,
the development of numerous small
units in close proximity makes littleThe Journasense from a health planning perspec-
tive. Regional cardiac centers shared
by multiple institutions would seem
to be a more rational approach.
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